Managing the neuroinflammatory pain of endometriosis in light of chronic pelvic pain.

IF 2.5 3区 医学 Q3 PHARMACOLOGY & PHARMACY Expert Opinion on Pharmacotherapy Pub Date : 2024-11-17 DOI:10.1080/14656566.2024.2425727
Joseph V Pergolizzi, Jo Ann LeQuang, Flaminia Coluzzi, Salah N El-Tallawy, Peter Magnusson, Rania S Ahmed, Giustino Varrassi, Maria Grazia Porpora
{"title":"Managing the neuroinflammatory pain of endometriosis in light of chronic pelvic pain.","authors":"Joseph V Pergolizzi, Jo Ann LeQuang, Flaminia Coluzzi, Salah N El-Tallawy, Peter Magnusson, Rania S Ahmed, Giustino Varrassi, Maria Grazia Porpora","doi":"10.1080/14656566.2024.2425727","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Endometriosis affects 5% to 10% of reproductive age women and may be associated with severely painful and debilitating symptoms as well as infertility. Endometriosis involves hormonal fluctuations, angiogenesis, neurogenesis, vascular changes and neuroinflammatory processes. The neuroinflammatory component of endometriosis makes it a systemic disorder, similar to other chronic epithelial inflammatory conditions.</p><p><strong>Areas covered: </strong>Inflammatory mediators, mast cells, macrophages, and glial cells play a role in endometriosis which can result in peripheral sensitization and central sensitization. There is overlap between chronic pelvic pain and endometriosis, but the two conditions are distinct. Effective treatment is based on a personalized approach using a variety of pharmacologic and other treatment options.</p><p><strong>Expert opinion: </strong>Hormonal therapies are a first-line approach, but endometriosis is a challenging condition to manage. 'Add-back' hormonal therapy has been effective. Painful symptoms are likely caused by the interplay of multiple factors and there may be a neuropathic component. Analgesics and anticonvulsants may be appropriate. A holistic approach and multimodal treatments are likely to be most effective. In addition to pharmacologic treatment, there are surgical and alternative medicine options. Endometriosis may also have a psychological component.</p>","PeriodicalId":12184,"journal":{"name":"Expert Opinion on Pharmacotherapy","volume":" ","pages":"1-16"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14656566.2024.2425727","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Endometriosis affects 5% to 10% of reproductive age women and may be associated with severely painful and debilitating symptoms as well as infertility. Endometriosis involves hormonal fluctuations, angiogenesis, neurogenesis, vascular changes and neuroinflammatory processes. The neuroinflammatory component of endometriosis makes it a systemic disorder, similar to other chronic epithelial inflammatory conditions.

Areas covered: Inflammatory mediators, mast cells, macrophages, and glial cells play a role in endometriosis which can result in peripheral sensitization and central sensitization. There is overlap between chronic pelvic pain and endometriosis, but the two conditions are distinct. Effective treatment is based on a personalized approach using a variety of pharmacologic and other treatment options.

Expert opinion: Hormonal therapies are a first-line approach, but endometriosis is a challenging condition to manage. 'Add-back' hormonal therapy has been effective. Painful symptoms are likely caused by the interplay of multiple factors and there may be a neuropathic component. Analgesics and anticonvulsants may be appropriate. A holistic approach and multimodal treatments are likely to be most effective. In addition to pharmacologic treatment, there are surgical and alternative medicine options. Endometriosis may also have a psychological component.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
根据慢性盆腔疼痛处理子宫内膜异位症的神经炎性疼痛。
简介子宫内膜异位症影响着 5%至 10%的育龄妇女,并可能导致严重的疼痛和衰弱症状,以及不孕症。子宫内膜异位症涉及激素波动、血管生成、神经生成、血管变化和神经炎症过程。子宫内膜异位症的神经炎症成分使其成为一种全身性疾病,与其他慢性上皮炎症类似:炎症介质、肥大细胞、巨噬细胞和神经胶质细胞在子宫内膜异位症中发挥作用,可导致外周敏感化和中枢敏感化。慢性盆腔疼痛和子宫内膜异位症之间存在重叠,但这两种疾病是截然不同的。专家意见:有效治疗的基础是采用多种药物和其他治疗方案的个性化方法:激素疗法是一线治疗方法,但子宫内膜异位症的治疗具有挑战性。后加 "激素疗法是有效的。疼痛症状可能是由多种因素相互作用造成的,其中可能有神经病理性因素。镇痛药和抗惊厥药可能是合适的。综合方法和多模式治疗可能最为有效。除药物治疗外,还可选择手术和替代疗法。子宫内膜异位症还可能与心理因素有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.60
自引率
3.10%
发文量
163
审稿时长
4-8 weeks
期刊介绍: Expert Opinion on Pharmacotherapy is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.
期刊最新文献
Letter to the editor - 'Olezarsen, a liver-directed APOC3 ASO therapy for hypertriglyceridemia'. Can we effectively manage binge eating disorder with pharmacotherapy? Systemic approaches in biliary tract cancers: a review in the era of multidirectional precision medicine. Managing the neuroinflammatory pain of endometriosis in light of chronic pelvic pain. "Shifting sands in cystic fibrosis": impacts of CFTR modulators on reproductive health in people with cystic fibrosis and challenges related to in utero exposure.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1